SMITH TODD N
Insider CIK 1523672 · OPHT SVP & CCO · HZNP SVP, Marketing & Alliance Mgmt · ZCOR President and CEO, Director · ASRT Director, Pres & CEO, Director · LTGO Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LTGO Latigo Biotherapeutics, In | A Award deriv | 2026-08-06 | 2026-08-10 | 105,542 | — | $0 | 105,542 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | A Award deriv | 2026-08-06 | 2026-08-10 | 105,542 | — | $0 | 105,542 | SEC↗ |
| ZCOR Zyla Life Sciences | D To issuer deriv | 2020-05-20 | 2020-05-21 | 180,000 | — | $0 | 0 | SEC↗ |
| ZCOR Zyla Life Sciences | D To issuer deriv | 2020-05-20 | 2020-05-21 | 241,500 | — | $0 | 0 | SEC↗ |
| ASRT Assertio Holdings, Inc. | A Award deriv | 2020-05-20 | 2020-05-22 | 603,750 | — | $0 | 603,750 | SEC↗ |
| ASRT Assertio Holdings, Inc. | A Award deriv | 2020-05-20 | 2020-05-22 | 450,000 | — | $0 | 450,000 | SEC↗ |
| ZCOR Zyla Life Sciences | D To issuer | 2020-05-20 | 2020-05-21 | 365,500 | — | $0 | 0 | SEC↗ |
| ASRT Assertio Holdings, Inc. | A Award | 2020-05-20 | 2020-05-22 | 644,925 | — | $0 | 644,925 | SEC↗ |
| ZCOR Zyla Life Sciences | A Award deriv | 2020-03-04 | 2020-03-05 | 241,500 | — | $0 | 241,500 | SEC↗ |
| ZCOR Zyla Life Sciences | A Award | 2020-03-04 | 2020-03-05 | 165,500 | — | $0 | 165,500 | SEC↗ |
| ZCOR Zyla Life Sciences | A Award deriv | 2020-01-02 | 2020-01-02 | 180,000 | — | $0 | 180,000 | SEC↗ |
| ZCOR Zyla Life Sciences | A Award | 2019-10-23 | 2019-10-24 | 200,000 | — | $0 | 200,000 | SEC↗ |
| OPHT Ophthotech Corp. | A Award deriv | 2015-01-02 | 2015-01-06 | 5,500 | — | $0 | 5,500 | SEC↗ |
| OPHT Ophthotech Corp. | A Award deriv | 2015-01-02 | 2015-01-06 | 1,400 | — | $0 | 1,400 | SEC↗ |
| OPHT Ophthotech Corp. | A Award deriv | 2014-10-03 | 2014-10-07 | 150,000 | — | $0 | 150,000 | SEC↗ |
| HZNP Horizon Pharma plc | D To issuer deriv | 2014-09-19 | 2014-09-22 | 6,699 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | D To issuer deriv | 2014-09-19 | 2014-09-22 | 70,000 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | D To issuer deriv | 2014-09-19 | 2014-09-22 | 61,000 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | D To issuer deriv | 2014-09-19 | 2014-09-22 | 21,880 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | D To issuer deriv | 2014-09-19 | 2014-09-22 | 41,250 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | D To issuer deriv | 2014-09-19 | 2014-09-22 | 62,000 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | D To issuer deriv | 2014-09-19 | 2014-09-22 | 18,955 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2014-09-19 | 2014-09-22 | 41,250 | — | $0 | 41,250 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2014-09-19 | 2014-09-22 | 61,000 | — | $0 | 61,000 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2014-09-19 | 2014-09-22 | 6,699 | — | $0 | 6,699 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2014-09-19 | 2014-09-22 | 21,880 | — | $0 | 21,880 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2014-09-19 | 2014-09-22 | 18,955 | — | $0 | 18,955 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2014-09-19 | 2014-09-22 | 70,000 | — | $0 | 70,000 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2014-09-19 | 2014-09-22 | 62,000 | — | $0 | 62,000 | SEC↗ |
| HZNP Horizon Pharma plc | D To issuer | 2014-09-19 | 2014-09-22 | 54,138 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | A Award | 2014-09-19 | 2014-09-22 | 54,138 | — | $0 | 54,138 | SEC↗ |
| HZNP HORIZON PHARMA, INC. | S Sale | 2014-05-19 | 2014-05-21 | 10,159 | $12.94 | $131.5K | 44,552 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise deriv | 2014-01-02 | 2015-02-04 | 13,750 | — | $0 | 41,250 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise | 2014-01-02 | 2015-02-04 | 13,750 | — | $0 | 54,711 | SEC↗ |
| HZNP HORIZON PHARMA, INC. | A Award deriv | 2014-01-02 | 2014-01-10 | 70,000 | — | $0 | 70,000 | SEC↗ |
| HZNP HORIZON PHARMA, INC. | A Award deriv | 2014-01-02 | 2014-01-10 | 62,000 | — | $0 | 62,000 | SEC↗ |
| HZNP HORIZON PHARMA, INC. | M Exercise deriv | 2013-12-09 | 2013-12-09 | 3,350 | — | $0 | 6,698 | SEC↗ |
| HZNP HORIZON PHARMA, INC. | M Exercise | 2013-12-09 | 2013-12-09 | 3,350 | — | $0 | 52,283 | SEC↗ |
| HZNP HORIZON PHARMA, INC. | S Sale | 2013-12-09 | 2013-12-09 | 10,000 | $6.93 | $69.3K | 40,961 | SEC↗ |
| HZNP HORIZON PHARMA, INC. | S Sale | 2013-12-09 | 2013-12-09 | 1,322 | $6.79 | $9.0K | 50,961 | SEC↗ |
| HZNP HORIZON PHARMA, INC. | A Award | 2013-12-05 | 2013-12-09 | 18,037 | — | $0 | 48,933 | SEC↗ |
| HZNP HORIZON PHARMA, INC. | A Award deriv | 2013-01-02 | 2013-01-03 | 61,000 | — | $0 | 61,000 | SEC↗ |
| HZNP HORIZON PHARMA, INC. | A Award deriv | 2013-01-02 | 2013-01-03 | 55,000 | — | $0 | 55,000 | SEC↗ |
| HZNP HORIZON PHARMA, INC. | S Sale | 2013-01-02 | 2013-01-03 | 6,998 | $2.36 | $16.5K | 22,570 | SEC↗ |
| HZNP HORIZON PHARMA, INC. | A Award | 2012-12-31 | 2013-01-03 | 22,500 | — | $0 | 29,568 | SEC↗ |
| HZNP HORIZON PHARMA, INC. | M Exercise deriv | 2012-12-10 | 2012-12-12 | 3,349 | — | $0 | 10,048 | SEC↗ |
| HZNP HORIZON PHARMA, INC. | M Exercise | 2012-12-10 | 2012-12-12 | 3,349 | — | $0 | 7,068 | SEC↗ |